Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin vs Cefuroxime Prophylaxis in Adult Cardiac Surgery
NCT04303390Phase 4Completed
- Sponsor
- Saud Al-Babtain Cardiac Center
- Start
- Feb 2018
- Primary completion
- May 2022
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin, cefuroxime in surgical site infection (SSI), sponsored by Saud Al-Babtain Cardiac Center. Started Feb 2018; status: completed.
02
Drugs
cefazolincefuroxime
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04303390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04303390.